Our approach

Optimizing global medical product development

Our approach is to keep an in-house team of development executives to handle the strategic planning and manage plan execution. Execution is done through a global network of validated and audited partners.

For European biotech companies this approach maximize the value creation through

• Easy access to a seasoned VP team of developers
• Track record from CMC through to commercialization
• Insight and experience to obtain key regulatory buy in from FDA and EMA
• Patient recruitment in key global geographies

For European pharmaceutical companies we add value through

• Combining European, US and Indian core competences when executing your studies
• Guiding and managing functional outsourcing of clinical development services
• Obtaining and maintaining global registrations through our network

This way we accelerate clinical development at reduced cost, add flexibility, and help companies expand their commercialization to the global market place. Learn more about our team.